(Q44044285)

29 November 2017

title

Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis (English)

1 reference

29 November 2017

main subject

visceral leishmaniasis

1 reference

Javier Moreno

2

0 references

author name string

Jose Luis Guarga

1

1 reference

29 November 2017

Javier Lucientes

3

1 reference

29 November 2017

Maria Jesús Gracia

4

1 reference

29 November 2017

Miguel Angel Peribáñez

5

1 reference

29 November 2017

Juan Antonio Castillo

6

1 reference

29 November 2017

publication date

1 September 2002

1 reference

Veterinary Immunology and Immunopathology

29 November 2017

published in

1 reference

29 November 2017

volume

88

1 reference

29 November 2017

issue

1-2

1 reference

29 November 2017

page(s)

13-20

1 reference

Functional diversity of helper T lymphocytes

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

An experimental model for canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Laboratory safety for arboviruses and certain other viruses of vertebrates. The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-Borne Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Immunology of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Immunological and histological study of T- and B-lymphocyte activity in canine visceral leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Modulating ongoing Th2-cell responses in experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Canine leishmaniasis. A review based on 95 cases in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2802%2900128-9

7 January 2021

10.1016/S0165-2427(02)00128-9

Identifiers

DOI

1 reference

29 November 2017

1 reference